Medical research

New treatment prevents transplant rejection

A new treatment strategy could increase the success rate of stem cell transplants, according to University of Queensland researchers.

Immunology

Immune-related adverse events up with checkpoint inhibitors

(HealthDay)—Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease, immune-related adverse events (irAEs), or both, events can often ...

Diseases, Conditions, Syndromes

Immunosuppressant response predicts aplastic anemia survival

(HealthDay)—Response to immunosuppressive therapy (IST) predicts overall survival (OS) in aplastic anemia (AA), according to a study published online Aug. 29 in the American Journal of Hematology.

Oncology & Cancer

What are risk factors for melanoma in kidney transplant recipients?

Kidney transplant patients appear to be at a greater risk of developing melanoma than the general population and risk factors include being older, male and white, findings that corroborate results demonstrated in other studies, ...

Oncology & Cancer

Single-dose PCV13 immunogenic, safe in pediatric oncology

(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.

Immunology

Deciphering an embryo-protecting protein

Revelations about a protein expressed in fetal cells could provide novel insights into its function and future immunosuppressive therapies.

page 1 from 4